This is the authors' abstract. We don't add key points for this paper.
BACKGROUND: The pathophysiology of idiopathic normal pressure hydrocephalus (iNPH) and its association with neurodegenerative disorders is poorly understood. OBJECTIVES: The aim was to determine the prevalence of α-synuclein pathology in iNPH and its associations with clinical characteristics. METHODS: We used α-synuclein seed amplification assay (synSAA) to retrospectively analyze cerebrospinal fluid (CSF) from a large single-center iNPH cohort (n = 144). Clinical assessments comprised Unified Parkinson's Disease Rating Scale part III, Mini-Mental State Examination, levodopa-challenge test, and olfactory identification test. Degenerative biomarkers (total-tau, phospho-tau, β-amyloid 1-42, and β-amyloid 1-40) were measured in CSF. RESULTS: A total of 30.1% of iNPH patients were synSAA+, and presented significantly more upper limb (UL) rigidity, hallucinations, and worse olfactory performance than synSAA- cases. Anosmia was higher in synSAA+ patients (64.0%) than synSAA- patients (15.3%). Clinical assessments and other biomarkers did not significantly vary with synSAA status. CONCLUSIONS: Underlying α-synuclein pathology is common in iNPH and presents with UL rigidity and olfactory dysfunction, suggesting a distinct synSAA+ phenotype in iNPH.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Weber et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: